Garlic
drugOn this page
Also known as Ae-garlicAllii bulbusAllii sativi bulbusAllium arenarium bulbAllium controversum bulbAllium longicuspis bulbAllium ophioscorodon bulbAllium pekinense bulbAllium sativumAllium sativum (garlic) bulb powderAllium sativum bulbAllium sativum bulb extractAllium sativum bulb powderAllium sativum extractAllium sativum ophioscorodonAllium sativum powderAllium sativum wholeB1233Cultivated garlic wholeDasuan
Summary
Garlic (CHEMBL2108463) is a phase-3 clinical-stage unknown; indicated across 4 conditions including alopecia areata and denture stomatitis.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- Indications: 4 conditions
- Clinical trials: 18
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2108463 |
| Name | Garlic |
| Type | Unknown |
| Max phase | 3 |
Also known as: Ae-garlic, Allii bulbus, Allii sativi bulbus, Allium arenarium bulb, Allium controversum bulb, Allium longicuspis bulb, Allium ophioscorodon bulb, Allium pekinense bulb, Allium sativum, Allium sativum (garlic) bulb powder, Allium sativum bulb, Allium sativum bulb extract
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
4 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| alopecia areata | 3 | MONDO:0005340 | EFO:0004192 |
| denture stomatitis | 2 | MONDO:0006723 | EFO:1000893 |
| follicular lymphoma | 2 | MONDO:0018906 | MONDO:0018906 |
1 further indication record had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.
Clinical trials
Total trials: 18.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 14 |
| PHASE4 | 1 |
| PHASE3 | 1 |
| PHASE2/PHASE3 | 1 |
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT00499460 | PHASE4 | COMPLETED | Effects of Garlic Supplements on Opioids in Healthy Volunteers |
| NCT02691117 | PHASE3 | TERMINATED | Topical Garlic Concentrate for Alopecia Areata in Children |
| NCT05050071 | PHASE2/PHASE3 | COMPLETED | Evaluation of Antibacterial Effect of Allium Sativum, Calcium Hydroxide and Their Combination in Infected Mature Teeth |
| NCT01198223 | PHASE2 | COMPLETED | Effect of Aqueous Extract of Garlic and Nystatin Mouthwash in Denture Stomatitis |
| NCT00079170 | Not specified | COMPLETED | Docetaxel Plus Garlic in Treating Patients With Locally Advanced or Metastatic Breast Cancer |
| NCT00122889 | Not specified | COMPLETED | Effects of Garlic Supplements on Drug Metabolism |
| NCT01293591 | Not specified | COMPLETED | Garlic Intake And Biomarkers Of Cancer Risk |
| NCT01948453 | Not specified | COMPLETED | Effect of Garlic Tablet Some Indicators Related to Atherosclerosis |
| NCT02322541 | Not specified | WITHDRAWN | Dietary Absorption of Garlic Metabolites Following Garlic Consumption |
| NCT03125551 | Not specified | WITHDRAWN | ROTEM and Dietary Supplements |
| NCT03795636 | Not specified | COMPLETED | Allium Sativum Extract as an Irrigant |
| NCT04646382 | Not specified | COMPLETED | Effect of a Mixture of Allium Extracts on LDL Cholesterol Levels Volunteers With Elevated LDL Cholesterol Levels |
| NCT04647071 | Not specified | COMPLETED | Allium Extracts on the Incidence of Respiratory Infection Symptoms in Healthy Elderly Volunteers |
| NCT05016999 | Not specified | COMPLETED | Allium Extracts on the Intestinal Microbiota in Healthy Resident Volunteers. |
| NCT05082350 | Not specified | UNKNOWN | Nutritional Intervention With Black Garlic |
| NCT05349253 | Not specified | COMPLETED | Effect of Garlic Extracts on Changes in Cerebral Blood Flow |
| NCT05349604 | Not specified | COMPLETED | Effect of Garlic Extracts on Changes in Blood Flow Velocity in the Carotid Artery |
| NCT05744752 | Not specified | UNKNOWN | Effects of Allium Sativum and Moringa Oleifera Extract on Dental Enamel |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
- Diseases: alopecia areata